Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Curated date: 2021/06/21
Curator: Itslanapark
Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Itslanapark, Peace Sandy
Subjects
- Location of subjects
- United States of America
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- HER2 Positive Breast Carcinoma ERBB2 Overexpressing subtype of breast carcinoma,HER2 Overexpressing breast carcinoma,HER2 Overexpressing subtype of breast carcinoma,HER2 Positive breast cancer,HER2 positive breast carcinoma,Her2-receptor positive breast cancer,HER2 Positive Breast Carcinoma,hER2 Positive Breast Carcinoma
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Her2 negative tumor
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Her2 positive tumor
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Breast cancer patients with Her2 positive tumors (human epidermal growth factor receptive 2 positive)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 25
- Group 1 sample size Number of subjects in the case (exposed) group
- 12
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- Antibiotic use one week or more during the month prior to fecal sample collection.
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Mann-Whitney (Wilcoxon)
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.001
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, ethnic group, race, Confounders controlled for: "total counts" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.total counts
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Table 3
Description: Mean ratio estimates found using zero-inflated negative binomial model of taxa abundance by HER2 status
Abundance in Group 1: increased abundance in Her2 positive tumor
NCBI | Quality Control | Links |
---|---|---|
Acidaminococcus |
Revision editor(s): Itslanapark
Signature 2
Source: Table 3
Description: Mean ratio estimates found using zero-inflated negative binomial model of taxa abundance by ER, PR, and HER2 status
Abundance in Group 1: decreased abundance in Her2 positive tumor
NCBI | Quality Control | Links |
---|---|---|
Desulfovibrio | ||
Ruminococcus | ||
Christensenellaceae |
Revision editor(s): Itslanapark, Claregrieve1
Experiment 2
Curated date: 2021/07/05
Curator: Itslanapark
Revision editor(s): WikiWorks, LGeistlinger, Itslanapark, Victoria
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Age at menarche Age at menarche,age at menarche
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- early age at menarche (≤11)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- later age at menarche (≥12)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- breast cancer patients with age at menarche being over 12 years old
- Group 0 sample size Number of subjects in the control (unexposed) group
- 11
- Group 1 sample size Number of subjects in the case (exposed) group
- 26
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- increased
Signature 1
Source: Table 5
Description: Mean estimate ratios gound using a zero-inflated negative binomial model of taxa abundances by age group, menarche age and parity.
Abundance in Group 1: increased abundance in later age at menarche (≥12)
NCBI | Quality Control | Links |
---|---|---|
Escherichia |
Revision editor(s): Itslanapark, Claregrieve1
Signature 2
Source: Table 5
Description: Mean estimate ratios found using a zero-inflated negative binomial model of taxa abundances by age group, menarche age and parity.
Abundance in Group 1: decreased abundance in later age at menarche (≥12)
NCBI | Quality Control | Links |
---|---|---|
Methanobrevibacter | ||
Ruminococcus |
Revision editor(s): Itslanapark
Experiment 3
Curated date: 2021/07/05
Curator: Itslanapark
Revision editor(s): WikiWorks, LGeistlinger, Itslanapark, Victoria
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Estrogen receptor status Estrogen receptor status,estrogen receptor status
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- ER+
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- ER-
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- breast cancer patients with negative Estrogen Receptor status
- Group 0 sample size Number of subjects in the control (unexposed) group
- 9
- Group 1 sample size Number of subjects in the case (exposed) group
- 28
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Table 3
Description: Mean ratio estimates obtained by zero-inflated negative binomial model of taxa abundances by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status.
Abundance in Group 1: decreased abundance in ER-
NCBI | Quality Control | Links |
---|---|---|
Haemophilus | ||
Veillonella |
Revision editor(s): Itslanapark
Experiment 5
Curated date: 2021/07/07
Curator: Itslanapark
Revision editor(s): WikiWorks, LGeistlinger, Itslanapark, Victoria
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Breast cancer breast cancer,breast tumor,cancer of breast,malignant breast neoplasm,malignant breast tumor,malignant neoplasm of breast,malignant neoplasm of the breast,malignant tumor of breast,malignant tumor of the breast,mammary cancer,mammary neoplasm,mammary tumor,primary breast cancer,Breast cancer
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Grade Low (I/II)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Grade High (III)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- breast cancer patients with grade high level tumors (Grade III)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 14
- Group 1 sample size Number of subjects in the case (exposed) group
- 23
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Table 4
Description: Mean estimate ratios found using zero- inflated negative binomial model of taxa abundances by grade and stage of breast cancer.
Abundance in Group 1: increased abundance in Grade High (III)
NCBI | Quality Control | Links |
---|---|---|
Eggerthella |
Revision editor(s): Itslanapark
Signature 2
Source: Table 4
Description: Mean estimate ratios found using zero- inflated negative binomial model of taxa abundances by grade and stage of breast cancer.
Abundance in Group 1: decreased abundance in Grade High (III)
NCBI | Quality Control | Links |
---|---|---|
Lachnospiraceae | ||
Anaerostipes |
Revision editor(s): Itslanapark
Experiment 6
Curated date: 2021/07/07
Curator: Itslanapark
Revision editor(s): WikiWorks, Claregrieve1, Itslanapark, Victoria
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Breast cancer stage Breast cancer stage,breast cancer stage
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Stage Low (I/II)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Stage High (III)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Breast cancer patients with high stage progression of breast cancer (Stage III).
- Group 0 sample size Number of subjects in the control (unexposed) group
- 22
- Group 1 sample size Number of subjects in the case (exposed) group
- 15
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Table 4
Description: Mean estimate ratios found using zero- inflated negative binomial model of taxa abundances by grade and stage of breast cancer.
Abundance in Group 1: increased abundance in Stage High (III)
NCBI | Quality Control | Links |
---|---|---|
Clostridium | ||
Veillonella | ||
Haemophilus |
Revision editor(s): Itslanapark
Signature 2
Source: Table 4
Description: Mean estimate ratios found using zero- inflated negative binomial model of taxa abundances by grade and stage of breast cancer.
Abundance in Group 1: decreased abundance in Stage High (III)
NCBI | Quality Control | Links |
---|---|---|
Acidaminococcus | ||
Catenibacterium |
Revision editor(s): Itslanapark
Experiment 7
Curated date: 2021/07/07
Curator: Itslanapark
Revision editor(s): WikiWorks, Claregrieve1, Itslanapark, Victoria
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Age Age,age
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Age 50+
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Age ≤50
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Breast cancer patients whose age is ≤50 years old.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 17
- Group 1 sample size Number of subjects in the case (exposed) group
- 20
Lab analysis
Statistical Analysis
- Statistical test
- Kruskall-Wallis
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- ethnic group, race, Confounders controlled for: "total counts" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.total counts
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Table 5
Description: Mean estimate ratios found using a zero-inflated negative binomial model of taxa abundances by age group, menarche age and parity.
Abundance in Group 1: increased abundance in Age ≤50
NCBI | Quality Control | Links |
---|---|---|
Clostridiaceae | ||
Clostridium | ||
Enterobacteriaceae | ||
Lactococcus |
Revision editor(s): Itslanapark
Experiment 8
Curated date: 2021/07/07
Curator: Itslanapark
Revision editor(s): WikiWorks, Claregrieve1, Itslanapark, Victoria
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Parous Parous,parous
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Parous
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Nulliparous
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Breast cancer patients who are nulliparous (have had no live births.)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 29
- Group 1 sample size Number of subjects in the case (exposed) group
- 8
Lab analysis
Statistical Analysis
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, ethnic group, race, Confounders controlled for: "total counts" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.total counts
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Table 5
Description: Mean estimate ratios found using a zero-inflated negative binomial model of taxa abundances by age group, menarche age and parity.
Abundance in Group 1: decreased abundance in Nulliparous
NCBI | Quality Control | Links |
---|---|---|
Catenibacterium |
Revision editor(s): Itslanapark
Experiment 9
Curated date: 2021/07/07
Curator: Itslanapark
Revision editor(s): WikiWorks, Claregrieve1, Itslanapark, Victoria
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Body mass index BMI,Quetelet's Index,Body mass index,body mass index
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- BMI<25
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- BMI≥25
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Breast cancer patients with a high body mass index (BMI≥25)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 9
- Group 1 sample size Number of subjects in the case (exposed) group
- 28
Lab analysis
Statistical Analysis
- Statistical test
- Mann-Whitney (Wilcoxon)
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Table 6
Description: Mean estimate ratios found using a zero-inflated negative binomial model of taxa abundances by BMI, total body fat, and physical activity.
Abundance in Group 1: increased abundance in BMI≥25
NCBI | Quality Control | Links |
---|---|---|
Akkermansia |
Revision editor(s): Itslanapark
Experiment 10
Curated date: 2021/07/07
Curator: Itslanapark
Revision editor(s): WikiWorks, Claregrieve1, Itslanapark, Victoria
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Body fat percentage Body fat percentage,body fat percentage
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- TBF≤46%
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- TBF>46%
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Breast cancer patients with a total body fat percentage ≥46%.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 25
- Group 1 sample size Number of subjects in the case (exposed) group
- 12
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- Not specified
Lab analysis
Statistical Analysis
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- Not specified
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- decreased
Signature 1
Source: Table 6
Description: Mean estimate ratios found using a zero-inflated negative binomial model of taxa abundances by BMI, total body fat, and physical activity.
Abundance in Group 1: increased abundance in TBF>46%
NCBI | Quality Control | Links |
---|---|---|
Clostridiaceae |
Revision editor(s): Itslanapark
Signature 2
Source: Table 6
Description: Mean estimate ratios found using a zero-inflated negative binomial model of taxa abundances by BMI, total body fat, and physical activity.
Abundance in Group 1: decreased abundance in TBF>46%
NCBI | Quality Control | Links |
---|---|---|
Coriobacteriaceae |
Revision editor(s): Itslanapark
Experiment 11
Curated date: 2021/07/08
Curator: Itslanapark
Revision editor(s): WikiWorks, Claregrieve1, Itslanapark, Victoria
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Physical activity Activities, Locomotor,Activities, Motor,Activities, Physical,Activity, Locomotor,Activity, Motor,Activity, Physical,Locomotor Activities,Locomotor Activity,Motor Activities,Motor Activity,Physical Activities,Physical activity,physical activity
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Yes Physical Activity
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- No Physical Activity
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Breast cancer patients who do not have regular physical activity.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 24
- Group 1 sample size Number of subjects in the case (exposed) group
- 13
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- Antibiotic use one week or more during the month prior to fecal sample collection.
Lab analysis
Statistical Analysis
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, ethnic group, race, Confounders controlled for: "total counts" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.total counts
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- decreased